PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28702823-0	2017	Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.	Doxorubicin	14-25	TNF superfamily member 10	Homo sapiens	106-111	
28702823-5	2017	In the TRAIL pre-treated cells, ET and DOX induced higher apoptosis, indicating their synergistic effect with TRAIL.	Doxorubicin	39-42	TNF superfamily member 10	Homo sapiens	7-12	
28702823-5	2017	In the TRAIL pre-treated cells, ET and DOX induced higher apoptosis, indicating their synergistic effect with TRAIL.	Doxorubicin	39-42	TNF superfamily member 10	Homo sapiens	110-115	
28702823-7	2017	The binding energy for TRAIL-DR5 complexation in the ternary complexes containing ET (-111.08 kcal/mol) and DOX (-76.35 kcal/mol) were higher than reported binding energy of binary complex (-53.70 kcal/mol).	Doxorubicin	108-111	TNF superfamily member 10	Homo sapiens	23-28